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Abstract
Background: Highly structured, supervised exercise training has been shown to be beneficial in patients with pulmonary hyper-
tension. Despite evidence of the effectiveness of community-based rehabilitation in other cardiopulmonary diseases, there are
limited data in patients with pulmonary hypertension.
Methods: This prospective study evaluated the intervention of a physiotherapist well-being review in patients with pulmonary
hypertension who had been established on targeted drug therapy for between 3 and 12 months. The intervention included
a detailed consultation assessing functional, social and motivational status to identify individual patient rehabilitation goals and
facilitate tailored referrals to community-based services.
Results: One hundred and thirty-eight patients (79% pulmonary arterial hypertension, 17% chronic thromboembolic disease), age
67 14 years, diagnosed over a one year period were evaluated between July 2017 and January 2018. Fifty-two per cent of patients
were referred to community-based pulmonary rehabilitation programmes, 19% received other forms of community rehabilitation,
17% were given exercise advice, 5% had an assessment of social support and 7% declined any intervention. At the end of the study,
32% of patients were undertaking independent exercise.
Conclusion: This study has identified that the majority of patients with pulmonary hypertension who are optimised on targeted
drug therapy have rehabilitation needs. The use of a physiotherapy well-being review can identify this need and facilitate access to
community-based rehabilitation. Further research is required to evaluate the efficacy of such interventions in pulmonary
hypertension.
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Introduction
Pulmonary hypertension is a life-shortening condition, vary-
ing from rare forms such as pulmonary arterial hypertension
(PAH) and chronic thromboembolic pulmonary hyperten-
sion (CTEPH) for which speciﬁc interventions exist to, usu-
ally milder, elevations of pulmonary artery pressure seen in
cardiac and respiratory disease.1,2 With the development of
advanced drug therapies,3 more people than ever are living
with pulmonary hypertension and for longer.4 However,
improvements in symptoms and/or survival do not necessar-
ily reﬂect the physical, emotional and psychological burdens
of living with pulmonary hypertension.5 This suggests the
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need to consider wider rehabilitative approaches in what is
now a chronic condition.
There has been increasing interest and a growing evidence
base for exercise training in patients with pulmonary hyper-
tension since the ﬁrst randomised controlled trial in 2006.6
It has now been established that exercise in patients with
pulmonary hypertension is safe and leads to improvements
in functional ability and quality of life.7,8While further work
is required to fully understand the physiological eﬀects of
exercise training in patients with pulmonary hypertension,9
change in skeletal muscle function and cardiac function as
well as reversal of pre-existing deconditioning are potential
mechanisms.10,11 In a systematic review of studies of exercise
therapy in pulmonary hypertension, Morris et al.12 demon-
strated improvements in six-minute walk distance of 60m as
well as signiﬁcant improvements in quality of life and only a
single adverse event (light-headedness during exercise) across
206 study participants. The recent European Respiratory
Society Task Force on exercise training in pulmonary hyper-
tension called for supervised exercise in physically stable,
deconditioned patients and for wider commissioning of
rehabilitation programmes in this patient group.13
To date, exercise studies have focused on rehabilitation
conducted in specialist pulmonary hypertension centres,
including a high number of inpatient rehabilitation
programmes14–16 which are not universally available and
which potentially exclude patients whose lifestyles are
unable to accommodate this approach. Consequently,
provision of rehabilitation for patients with pulmonary
hypertension is not yet universal standard care.17
Establishing new in-patient rehabilitation programmes
where they do not exist would have considerable cost impli-
cations. Community-based rehabilitation programmes,
including pulmonary rehabilitation, are widely and success-
fully used in the care of patients with other respiratory con-
ditions.18 The potential for out-patient and home-based
exercise training in pulmonary hypertension has been
reported.19,20 However, while such programmes can oﬀer
greater ease of access for patients, they are likely to be
delivered by staﬀ who lack specialist knowledge of pulmon-
ary hypertension and may therefore provide rehabilitation
which is sub-optimal.
The aim of this study was to examine whether a specialist
physiotherapist well-being review can identify the individual
rehabilitation needs and goals of patients with pulmonary
hypertension and investigate whether these needs can be
addressed by referral to community-based services.
Methods
Setting
This was a prospective study of a new service that consisted
of physiotherapy well-being reviews of patients with
pulmonary hypertension under the care of a UK regional
pulmonary hypertension specialist centre, which serves
a referral population of in excess of 15 million, with more
than 1600 patients receiving targeted drug therapies for pul-
monary hypertension. Patients supported by the centre live
in a mix of rural and urban areas, travelling up to 200 miles
(approximately 6 hour commute) to attend appointments.
Study population
Patients who were commenced on targeted pulmonary
hypertension drug therapy between October 2016 and
October 2017 were considered for inclusion in the study.
Patients underwent the initial physiotherapy well-being
review between July 2017 and January 2018. Follow-up con-
tinued until the end of January 2019, 12 months after the
last patient was enrolled.
Inclusion and exclusion criteria
Patient records were reviewed to identify patients suitable
for physiotherapy assessment.
Patients included in the study were adults> 18 years diag-
nosed with pulmonary hypertension21 who had been com-
menced on targeted pulmonary hypertension drug therapy
within the study time period and had been established on
treatment for at least 3 months but less than 12 months and
attended clinic within the recruitment window. Patients were
excluded from the study if they were on a pathway for pul-
monary endarterectomy surgery, had recently undergone
surgery, had uncorrected congenital heart disease or were
seen by a shared care centre during the follow-up period
(shared care arrangements exist between the specialist
centre and nationally designated congenital heart disease
centres). Patients who were identiﬁed, on screening,
as not being stable were excluded, i.e. patients who had
deteriorated since their last review or required change in
their targeted pulmonary hypertension therapies. Disease
severity or functional ability was not used as an inclusion
or exclusion criteria.
Intervention
Physiotherapy well-being review. Patients meeting the inclusion
criteria were approached by a physiotherapist specialising
in pulmonary hypertension while they attended routine
out-patient/day-case clinics at a pulmonary hypertension
specialist centre.
Patients underwent a well-being22 review conducted by
the physiotherapist. This is a novel intervention newly
devised for this study based on the clinical experience
of the physiotherapist and other members of the multi-
disciplinary team. The physiotherapist conducted a well-
being review which took the form of an individualised
one-to-one clinical assessment capturing objective and
subjective information to identify the patients’ current
functional ability and exercise activity. The information
was assimilated to identify rehabilitation needs and
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functional and rehabilitation goals before discussing and
agreeing with the patient suitable options for onward
rehabilitation referral. Well-being reviews typically lasted
between 15 and 45min depending on the individual patient.
The physiotherapist captured a detailed history including
the presence or absence of comorbidities; social and eco-
nomic status; functional ability, limitations and independ-
ence; weight and diet behaviour; current and previous levels
of physical activity and exercise; emotional well-being; par-
ticipation in work, education, training or recreation; experi-
ences, beliefs and attitudes to exercise and physical activity;
motivation for rehabilitation and change. Where available,
information was also captured from carers to gain further
detail and insight into the patients’ experience of living with
pulmonary hypertension and its impact on the lives of the
patient and those around them.
Physical examination included height, weight, body-mass
index, oxygen saturations, heart rate, blood pressure and
assessment for the presence or absence of heart failure.
WHO functional class,2 emPHasis-10 quality of life
score,23 Incremental Shuttle Walking Test distance
(ISWT)24,25 and right heart catheter results were also noted.
All of the objective markers are clinical measures rou-
tinely used in the specialist centre in which the study was
conducted. No additional assessments, beyond those which
are routinely used in clinical assessment, were carried out for
the study.
The well-being review oﬀer and structured content was
common for each patient, regardless of their diagnosis or
WHO functional class. A universal structure was followed
for every review; however, the detailed content of each
individual’s review and their expected outcomes varied
in response to each patient’s status and needs which were
identiﬁed for each individual during the well-being review.
Community referral. The physiotherapist drew on the ﬁndings
of the well-being review to identify primary patient charac-
teristics and establish functional priorities and goals for
rehabilitation. From this, discussions were held with
patients to identify the most suitable method to address
their rehabilitation needs and goals (Fig. 1). This could
include onward referral to community rehabilitation (pul-
monary rehabilitation, community or domiciliary therapy,
musculo-skeletal physiotherapy), exercise advice or an
assessment for social support. Full details of rehabilitation
services used in the study are given in Table 1. Where
patients declined support, advice or referral to rehabilita-
tion, they were given written information on ways to
increase levels of physical activity.
Safety and specialist support. To address the potential lack of
knowledge of pulmonary hypertension in local rehabilita-
tion programmes, detailed information concerning the
patient and the condition were provided within referrals.
This included information on the characteristics of pulmon-
ary hypertension and speciﬁc guidance on any limitations to
exercise for each patient. Additionally, each patient was
advised on safe exercise practice for them. Community
rehabilitation services have their own risk assessment and
safety procedures in place which will be applied to all
patients taking part in rehabilitation. The pulmonary hyper-
tension specialist physiotherapist was available to service
Fig. 1. Diagnostic process map.
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providers and patients for any queries during the rehabili-
tation period, including those relating to patient safety
during exercise. Data were not formally collected on the
number and nature of these queries. Details of contacts
with third parties were recorded in contemporaneous clinical
patient notes.
Follow-up outcomes. Patients were seen on their return to
clinic (typically between three and six months after their
initial physiotherapy well-being review) and reassessed by
the physiotherapist. Repeat measures for ISWT and
emPHasis10 were extracted from routine clinical data.
Current levels of patient activity were subjectively assessed
(Table 2) through clinical interview by the physiotherapist
along with information regarding whether the patient had
attended or completed any rehabilitation programmes and
the reasons behind this. Where indicated by clinical assess-
ment and discussion with the patient, referral to further
rehabilitation services or targeted exercise advice was pro-
vided (Fig. 1). The physiotherapy goal was to continue to
support patients until they were exercising independently or
with the support of a long-term community rehabilitation
programme, or until the physiotherapist judged that the
patient was as active as they were likely to be within the
constraints of their functional ability and motivation.
Additional data. Information was logged throughout the pro-
ject to capture practical or process issues that limited or
facilitated the smooth administration of the intervention.
This was obtained through contemporaneous clinical notes
which were taken at each patient clinic visit and also on any
patient-related activity, e.g. patient phone calls, referral cor-
respondence and contact with third parties involved in the
patient care or provision of rehabilitation services.
Statistical analysis
Descriptive statistics including mean, standard deviation
and range were used to analyse patient demographic and
outcomes from the physiotherapy well-being review.
Results
Study population
Of 310 patients screened for entry into the study, 172 were
excluded (see Table 3 for reasons) leaving a total of 138
patients who received a physiotherapy well-being review.
Table 1. Referral options offered to patients during the study.
Referral options Details
Pulmonary rehabilitation Pulmonary rehabilitation is an interdisciplinary programme of care for patients with chronic respiratory
impairment comprised of individualised exercise programmes and education.26
Community or
domiciliary therapy
Patients with poor mobility, history of falls or with limited functional independence can benefit from a therapy
assessment at home by physiotherapy or occupational therapy. This may result in, e.g. home adaptations or
equipment provision; improved functional ability; referral to care services which can help to prolong inde-
pendence and avoid hospital admission.
Musculo-skeletal
physiotherapy
Some patients, while limited by breathlessness, cite other comorbidities which are the limiting factors in their
physical activity, e.g. knee or back pain, which can be addressed through specialist physiotherapy assessment.
Other community
rehabilitation
A wide range of rehabilitation programmes are provided by local authorities and charities which provide exer-
cise, activity and social activity in a variety of community settings. Examples include exercise-on-prescription
schemes, community walking groups, singing for health; tai chi groups etc.
Exercise advice – low
level exercise
Patients with very sedentary lifestyles were offered advice on small incremental steps to becoming more active
and supported to develop confidence in their physical capabilities, with a view to engaging them in other future
rehabilitation activities.
Exercise advice – high
level exercise
Patients who were already exercising regularly were given advice on guidelines regarding the amount and type of
exercise recommended This needs to be added as a reference as follows: NHS England Physical Activity
Guidelines (2018) https://www.nhs.uk/live-well/exercise/ and approaches to staying motivated and adapting
exercise routines to change in circumstances.
Assessment of social
support
Where patients were too unwell to undertake any form of rehabilitation, levels of home social and functional
support were identified and addressed as needed.
Table 2. Levels of patient activity.
Activity levels Details
Low activity These patients would be largely based at home,
rarely going out. They might perhaps be sup-
ported by carers and live on a single level or
have a stair lift
Active not
exercising
Patients who are able to get about and participate
in domestic activities of daily living, social or
work activities
Community
rehabilitation
Regularly engaging in a community rehabilitation
programme
Exercising
independently
Going to the gym, carrying out a home exercise
programme, regular walks for exercise
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Patient demographics are shown in Table 4. The majority of
patients had PAH (79%), while 17% had a diagnosis of
CTEPH, comprising either inoperable disease or residual
disease following surgery and 4% had Group 5 pulmonary
hypertension.1
The study population included patients with a wide range
of disease severity and functional ability as shown by the
variation in values at diagnosis for mPAP (25–81mmHg),
ISWT (0–720m) and emPHasis10 (score of 2–50) as shown
in Table 4.
Community referrals
The most common outcome from the physiotherapy well-
being review was referral to local pulmonary rehabilitation
programmes (52%). Referrals to other forms of community-
based rehabilitation were made for 19% of patients; this
included one patient who was initially referred for pulmonary
rehabilitation but transferred to cardiac rehabilitation by the
service provider and another who was referred to cardiac
rehabilitation due to a myocardial infarction in the preceding
three months. A further 17% of patients were given exercise
advice and the 5% who were identiﬁed as being too unwell to
beneﬁt from rehabilitation had an assessment of their social
support at home (Table 5). Seven per cent of patients had an
identiﬁed rehabilitation need, but declined the opportunity of
a referral and were instead given written advice on increasing
their levels of physical activity.
During email or phone call contact regarding referrals or
advice, clinicians in local services reported that they valued
Table 4. Patient demographics at diagnosis.
Characteristics PAH (n¼ 109) CTEPH (n¼ 23) Other (n¼ 6) All (n¼ 138)
Age, mean (SD), y 66.4 (14.3) 73.3 (10.2) 63.7 (10.1) 67.5 (13.8)
Female, no. (%) 77 (70.1) 9 (39.1) 2 (33.3) 88 (63.8)
WHO FC, no. (%)
Class II 1 (0.9) 1 (4.3) 0 (0) 2 (1.4)
Class III 85 (78.0) 21 (91.3) 6 (100.0) 112 (81.2)
Class IV 23 (21.1) 1 (4.3) 0 (0.0) 24 (17.4)
ISWT, mean (range), m 124 (0–590) 190 (0–720) 163 (40–320) 137 (0–720)
Haemodynamics
mPAP, mean (SD), mmHg 49 (12) 45 (11) 42 (5) 48 (12)
mRAP, mean (SD), mmHg 11 (6) 10 (4) 9 (8) 11 (6)
PAWP, mean (SD), mmHg 11 (5) 11 (4) 10 (4) 11 (5)
CO (l/min) 3.85 (1.69) 3.87 (1.21) 3.5 (1.07) 3.84 (1.58)
CI (l/min/m2) 2.09 (0.83) 2.04 (0.57) 1.64 (0.39) 2.06 (0.78)
PVR (dynes/m2) 896 (486) 672 (306) 806 (313) 855 (459)
emPHasis10, mean (SD), score out of 50 31 (11) 28 (11) 29 (5) 31 (11)
WHO FC: World Health Organization functional class; PAH: pulmonary arterial hypertension; CTEPH: chronic thromboembolic pulmonary hypertension.
Haemodynamics measure at right heart catheterisation: mRAP: mean right atrial pressure; mPAP: mean pulmonary arterial pressure; PAWP: pulmonary arterial
wedge pressure; CO: cardiac output; CI: cardiac index; PVR: pulmonary vascular resistance.
Table 3. Reasons for exclusion from study.
Reason for exclusion n¼ 172
Number of
patients (%)
Not reviewed/did not attend a clinic
appointment within study time period
68 (39.5)
Seen by shared care centre
(congenital heart disease)
59 (34.3)
On a pathway for pulmonary endarterectomy 33 (19.2)
Not stable on current PH treatment 6 (3.5)
Uncorrected congenital heart disease
under local follow-up
4 (2.3)
Recently undergone surgery 1 (0.6)
Pregnancy 1 (0.6)
PH: pulmonary hypertension.
Table 5. Physiotherapy well-being review results.
Well-being review outcome, n¼ 138
Number of
patients (%)
Pulmonary rehabilitation 72 (52.2)
Exercise advice given – high-level function 17 (12.3)
Community or domiciliary therapy 16 (11.6)
Patient declined support 9 (6.5)
Exercise advice given – low-level function 7 (5.1)
Other community rehabilitation 9 (6.5)
Assessment of social support 7 (5.1)
MSK physiotherapy referral 1 (0.7)
MSK: musculo-skeletal.
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the triage of patients by a physiotherapist specialising in
pulmonary hypertension prior to referral as well as acknowl-
edging that easy access to the expertise of the physiotherap-
ist increased their understanding and conﬁdence in
rehabilitation of this patient group. Challenges arose
when making referrals for six patients where pulmonary
rehabilitation was the preferred referral option but was
not commissioned for patients with pulmonary hypertension
within their area. In three instances, this was resolved
through discussion with service providers; where this was
not possible, alternative rehabilitation arrangements were
made.
Patients in the study lived in a wide geographical area,
covering the centre of the UK, with the furthest patient
living over 150 miles away. Reﬂective of this geographical
spread, referrals were made to 69 rehabilitation services
across the region.
Safety and specialist support
No safety issues were reported by patients during clinical
assessments or by rehabilitation service providers during
discussions of referrals or requests for advice, although
information on adverse events was not actively sought. In
some instances, providers of services contacted the referring
physiotherapist to clarify guidance on rehabilitation proto-
cols for individual patients or in general for patients with
pulmonary hypertension.
Follow-up outcomes
Of the 74 patients referred to pulmonary or cardiac rehabili-
tation programmes, 36 (48%) completed the full rehabilita-
tion programme, 14 (19%) started rehabilitation and did
not complete, while 24 (32%) did not start. At follow-up
assessment, common reasons given by patients for non-
completion included other health problems, diﬃculty travel-
ling to rehabilitation and lengthy waiting times to
commence rehabilitation. Some patients with work or
caring responsibilities reported that the timing of pulmonary
rehabilitation classes (which tend to be during the working
day) did not meet their needs, while others found the
programmes to be targeted at patients with COPD and
therefore not well suited to them.
Measurements for ISWT and emPHasis10 were taken for
104 patients before and after rehabilitation. These data were
collected at routine clinic appointments and therefore do not
directly coincide with start and end of rehabilitation; the
time period between measures varied from 3 to 12 months.
Fifty-eight (42%) patients showed an improvement in
functional ability (increase in ISWT of 40m) or an
improvement in quality of life (increase in emPHasis10 of
6 or more (out of 50)).
At follow-up, clinical assessment was made by the
physiotherapist of the patients’ current level of activity
(Table 6). The largest group (38%) were considered to be
active, but not exercising, while 32% were exercising
independently. Low levels of activity were identiﬁed in
21% of patients, while 6% were engaged in community
rehabilitation.
Discussion
Need for rehabilitation
This study has shown that the majority of patients with pul-
monary hypertension receiving targeted drug therapy within
the ﬁrst year of diagnosis have rehabilitation needs. The use
of a well-being review delivered by a physiotherapist specia-
lising in pulmonary hypertension can identify this need and
facilitate access to community-based rehabilitation.
To our knowledge, this is the ﬁrst study to establish the
extent of the need for rehabilitation in newly diagnosed
patients with pulmonary hypertension who are optimised
on targeted drug therapy. With 88% of patients receiving
either referral for exercise rehabilitation or targeted exercise
advice, the study results demonstrate a clear need for the
provision of rehabilitation for patients with pulmonary
hypertension to enhance their well-being. By engaging
patients in rehabilitation once they are optimised on drug
therapy, there is an opportunity to build on the functional
gains that might be achieved through pharmaceutical sup-
port to achieve further improvements in well-being. Further
work is required to identify optimal timing of these inter-
ventions and the nature and extent of change that can be
made to patient well-being; however, Fig. 2 is an illustration
which indicates the potential gains achievable through
timely rehabilitation interventions.12,27
Uptake of rehabilitation
Along with high levels of need, there were high levels of
engagement with rehabilitation in the study. Referrals to
pulmonary rehabilitation were accepted by 54% of patients
and to other community-based rehabilitation by 17% of
patients. Despite reports from some patients that they
found their pulmonary rehabilitation to be focused on
COPD and therefore not always entirely suited to them,
commencement and completion rates for pulmonary
rehabilitation at 68% and 48%, respectively, are compar-
able with data for pulmonary rehabilitation in patients with
Table 6. Follow-up outcomes.
Follow-up outcome n¼ 138
Number of
patients (%)
Active, not exercising 52 (37.7)
Exercising independently 44 (31.9)
Low levels of activity 29 (21.0)
Community rehabilitation 6 (4.3)
Deceased 7 (5.1)
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COPD where 67% commenced and 46% completed
rehabilitation.28 Further research into the eﬀectiveness and
cost-eﬀectiveness of pulmonary rehabilitation in patients
with pulmonary hypertension is currently underway.29
The levels of physical activity at follow-up, with 32% of
patients exercising independently and 6% participating
in community rehabilitation programmes, are indicative of
the potential for rehabilitation in patients with pulmonary
hypertension. In studies of exercise training in patients with
pulmonary hypertension, Chan et al.30 and Weinstein et al.31
both demonstrate signiﬁcant increases in levels of physical
activity in patients undergoing rehabilitation as measured by
physical activity questionnaires. Further work is required to
explore outcomes relating to physical activity, which might
include patient report outcomes measures or wearable
devices,32 to determine their potential use in pulmonary
hypertension rehabilitation.
The current study was universal in its inclusion, assessing
and treating patients with even the most severe disease
whose outcomes might be expected to be poor. Despite
this, and despite the progressive nature of the disease, our
data show some positive indications that the intervention
can improve function and quality of life.
Inclusive rehabilitation
The intervention in this study was able to meet the diverse
rehabilitation needs of this complex patient group. Patients
with pulmonary hypertension vary signiﬁcantly in terms of
age, functional ability, disease history and severity. While
some patients with pulmonary hypertension are signiﬁcantly
limited functionally, others might be in work or have caring
responsibilities. This, combined with the wide geographical
spread of patients from their regional specialist centres, can
make delivery of rehabilitation challenging. Patients will
have preferences for the time, location and nature of
the rehabilitation in which they are prepared to engage.
The physiotherapy well-being review and onward referral
to community rehabilitation are able to accommodate this
wider rehabilitation and thus suggest the requirement for
rehabilitation solutions tailored to the individual rather
than one-size-ﬁts-all solutions.
This study was pragmatic in design and shows that it is
feasible to deliver community-based rehabilitation to
patients with pulmonary hypertension within existing
healthcare service provision. Participants were not required
to attend any additional appointments; instead, their well-
being review took place around the normal clinical activity
of a standard clinical visit. The rehabilitation services
accessed by patients in this study were pre-existing and
widely available in community settings, without the need
to establish bespoke and potentially expensive services for
patients with pulmonary hypertension.
Role of the physiotherapist
The expertise of the specialist physiotherapist was important
in ensuring that the community-based rehabilitation met the
needs of patients with pulmonary hypertension. Professionals
delivering rehabilitation in community settings will be experts
in rehabilitation, but may have limited knowledge of its appli-
cation in this rare disease. The specialist physiotherapist role
oﬀers a combined expertise in pulmonary hypertension and
rehabilitation along with access to the resources of a specialist
pulmonary hypertension referral centre. They share a profes-
sional language and framework of understanding of rehabili-
tation with community providers. By delivering detailed
expert referrals and being easily available for questions or
concerns, the specialist physiotherapist has facilitated the pro-
vision of eﬀective community-based rehabilitation to a com-
plex patient group with a rare disease.
The specialist physiotherapist also had an important role
to play in supporting the safety of the intervention. Within
the physiotherapy well-being review, patients who were
identiﬁed as higher risk for exercise were directed towards
more closely supervised rehabilitation programmes, e.g. pul-
monary rehabilitation which oﬀers physiotherapy and nur-
sing support to patients. Detailed information concerning
the patient and the condition were provided in referrals,
and patients were advised on safe exercise practice.
Fig. 2. The potential effect of rehabilitation on patient well-being.
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The optimal model of rehabilitation in pulmonary hyper-
tension has yet to be determined and may vary according to
country or setting,10 but it is likely that any sustainable
expansion of rehabilitation in pulmonary hypertension will
require an associated expansion of physiotherapy provision
for patients with pulmonary hypertension and in education
and access to resources for community-based rehabilitation
services. This study demonstrates a model of care for
rehabilitation which allows patients to access a community
rehabilitation service local to them while maintaining the
support and access to the expertise of their specialist
centre. The tailored, individualised approach allows the
best rehabilitation solution to be delivered to patients
based on their needs, rather than oﬀering a one-size-ﬁts-all
solution. Physiotherapy skills and knowledge have been at
the core of the intervention and its outcomes.
Next steps
The positive indication for the outcomes of functional abil-
ity and quality of life and the practical success of the study
suggests that more work should be done to establish its
eﬀectiveness in comparison to a control group. The next
step would be to undertake a feasibility study of a rando-
mised controlled trial of the intervention to establish eﬃcacy
of the intervention and beneﬁt to patients. The acceptability
of the intervention to patients and clinicians would also need
to be examined along with the outcome measures best-suited
to capturing the impact of such interventions. It is import-
ant to explore the importance of patient well-being and
rehabilitation in the commissioning of pulmonary hyperten-
sion specialist services.
Limitations
The pragmatic nature of this study leads to limitations
which are manifest in the variable timeframes over which
follow-up outcomes were collected. Outcomes were not uni-
formly separated by time, nor speciﬁcally aligned with the
start and ﬁnish of patient rehabilitation which may detract
for their eﬀectiveness in detecting change. Levels of physical
activity were not captured at the outset of the study, and
therefore it was not possible to compare values before and
after the intervention, which would have enhanced the study
results. Reﬂective of the real-world nature of the study, there
is no control of the content or quality of the rehabilitation
undertaken by patients. While no major adverse events were
reported by rehabilitation providers or patients, we cannot
rule out the occurrence of minor events; this would be better
addressed in a controlled trial.
Conclusion
The study has identiﬁed an unmet need in the provision of
rehabilitation to patients with pulmonary hypertension who
are optimised on targeted drug therapy. The use of a
physiotherapy well-being review can identify this need and
facilitate access to community-based rehabilitation. Further
research is required to evaluate the eﬃcacy of such interven-
tions in pulmonary hypertension.
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